JPRN-UMIN000002837
Completed
未知
Safety, efficacy and immunogenicity of autologous tumor lysate-pulsed dendritic cell therapy after resection of stage2A (T2N0,T3N0) esophageal cancer - Autologous tumor lysate-pulsed dendritic cell therapy after resection of esophageal cancer
ConditionsEsophageal cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Esophageal cancer
- Sponsor
- The University of Tokyo Hospital
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have: \-Pulmonary fibrosis or interstitial pneumonia, including their history or predisposition; \-Serious drug allergy; \-Difficult infections to control; \-Serious cardiac diseases; \-Active autoimmune diseases; \-Other cancers; \-Continuous systemic administration of steroids and/or immunosuppressants within 4 weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Immunological response and safety of autologous dendritic cells in triple-negative breast cancer (TNBC) patients who have received curative surgery after neoadjuvant chemotherapy(NCT).NeoplasmsKCT0002931Dongnam Institute of Radiological & Medical Sciences50
Not yet recruiting
Phase 1
Investigation of treatment of patients with refractory breast cancer using autologous immune cells enriched with NK cellsIRCT20160419027479N2VC for Research and Technology and Institute for stem cells and regenerative medicine, Shiraz Unive3
Not yet recruiting
Phase 1
Safety and clinical effectiveness of autologous mesenchymal stromal cell infusion as adjuncttreatment in patients with Idiopathic Pulmonary FibrosisJ84.1Other interstitial pulmonary diseases with fibrosisDRKS00008790The Republican Research and Practical Centre for Pulmonology and TB40
Not yet recruiting
Phase 1
Safety, preliminary efficacy and immunogenicity of traditional Chinese medicine miRNA hydrogel in the treatment of eczema: a randomized, double-blind, placebo-controlled, dose-increasing clinical studyeczemaITMCTR2000003604Shanghai Skin Disease Hospital
Completed
Phase 1
The safety and efficacy of autologous concentrated bone marrow grafting in the treatment of osteonecrosis and non-unioosteonecrosis, non-union (not infected)JPRN-UMIN000020940Department of Orthopaedics Surgery, Faculty of Medicine, University of Tsukuba20